New York, December 12, 2013 / Accesswire / -- Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Sarepta Therapeutics Inc(NASDAQ:SRPT), Lululemon Athletica inc.(NASDAQ:LULU), Canadian Solar Inc.(NASDAQ:CSIQ), Synta Pharmaceuticals Corp.(NASDAQ:SNTA).
Sarepta Therapeutics Inc(NASDAQ:SRPT) is sharply higher amid today's Duchenne Policy Forum from Parent Project Muscular Dystrophy (live stream here) where the FDA's Janet Woodcock may have made some comments supportive of eteplirsen's regulatory timelines.
Free Urgent Insider Catalyst Report For SRPT Available Here: http://marketbuzzreport.com/index.php?code=SRPT (Or Copy and paste the URL into your browser)
Lululemon Athletica inc.(NASDAQ:LULU) explanation of its PR issue indicates the Luon yoga pants issue dented the brand reputation a bit more than expected. The resignation of CEO Christine Day and ill-timed comments from the company's founder are also in the background.Flat comparable store sales growth is expected for Q4 despite a strong performance from the company's e-commerce business. Execs say 2/3 of the weak guidance is tied to slow traffic and 1/3 from product issues.Penetration for e-commerce increased to over 16% as new channels have been introduced.Gross margin rate is expected to slip to the mid-50s in Q4.With sales running behind schedule, promotions will have to be increased in some categories.
Free Urgent Insider Catalyst Report For LULU Available Here: http://marketbuzzreport.com/index.php?code=LULU (Or Copy and paste the URL into your browser)
Canadian Solar Inc.(NASDAQ:CSIQ) is supplying 100MW of solar modules to Chinese solar systems integrator Zhenfa New Energy for use in four projects. Deliveries are expected to start in mid-December, and be finished in January. (PR)The announcement comes three days after Canadian said it has obtained a $40M loan to finance Japanese solar projects, and is supplying 8.7MW of modules for a Mexican project.
Free Urgent Insider Catalyst Report For CSIQ Available Here: http://marketbuzzreport.com/index.php?code=CSIQ (Or Copy and paste the URL into your browser)
Synta Pharmaceuticals Corp.(NASDAQ:SNTA) +15% premarket after announcing "positive" Interim results from the ENCHANT-1 trial of ganetespib in metastatic breast cancer at a breast cancer symposium.Early results demonstrated the drug is clinically active as a single-agent in both HER2+ and triple-negative metastatic breast cancers, SNTA says.
Free Urgent Insider Catalyst Report For SNTA Available Here: http://marketbuzzreport.com/index.php?code=SNTA (Or Copy and paste the URL into your browser)
USMarketBuzz.com is an investment community that Focuses on MicroCap Securities. USMarketBuzz.com is an authorative authentic Google News Site and Leading Provider of Investment Awareness and Featured Company Profiles. If you would like more information regarding our news coverage solutions, please visit http://www.USMarketBuzz.com/ for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.USMarketBuzz.com/. Follow us on Facebook: https://www.facebook.com/usmarket.buzz Sign up for our FREE SMS News alerts delivered directly to your mobile phone by texting the word PREPROMO to 27126. (SMS alerts are free, however data rates may apply, check your wireless plan for details.)